Free Trial

Replimune Group (REPL) SEC Filings & 10K Form

$5.01
-0.17 (-3.28%)
(As of 05/29/2024 ET)

Recent Replimune Group SEC Filings

DateFilerForm TypeView
05/23/2024
3:17 PM
Esposito Pamela (Reporting)
Replimune Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
7:00 PM
Replimune Group (Issuer)
Xynos Konstantinos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:01 PM
Patel Sushil (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:02 PM
Coffin Robert (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:04 PM
Astley-Sparke Philip (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:05 PM
Love Colin (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:06 PM
Replimune Group (Issuer)
Schwendenman Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:06 PM
Replimune Group (Issuer)
Sarchi Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
8:07 AM
Replimune Group (Filer)
Form POS AM
05/16/2024
8:10 AM
Replimune Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/16/2024
7:08 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
7:11 AM
Replimune Group (Filer)
Form POSASR
05/16/2024
7:14 AM
Replimune Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2024
11:58 AM
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Replimune Group (Subject)
Form SC 13G/A
04/10/2024
8:48 AM
Replimune Group (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
04/03/2024
7:00 PM
Replimune Group (Issuer)
Schwendenman Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:00 PM
Levitsky Hyam (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:00 PM
Oliger Christy J. (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:00 PM
Replimune Group (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:01 PM
Replimune Group (Issuer)
SLATTERY JOSEPH P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:01 PM
Replimune Group (Issuer)
Sarchi Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:01 PM
Hill Emily Luisa (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:01 PM
Dhingra Kapil (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:02 PM
Replimune Group (Issuer)
Xynos Konstantinos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:02 PM
Pucci Paolo (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:03 PM
Patel Sushil (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:04 PM
Peeples-Dyer Veleka (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:33 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:44 PM
Omega Fund IV, L.P. (Filed by)
Replimune Group (Subject)
Form SC 13G/A
02/14/2024
6:21 AM
Forbion Capital Fund III Cooperatief U.A. (Filed by)
Replimune Group (Subject)
Form SC 13G/A
02/09/2024
11:09 AM
MORGAN STANLEY (Filed by)
Replimune Group (Subject)
Form SC 13G
02/08/2024
7:05 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
7:09 AM
Replimune Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/25/2024
5:58 AM
Replimune Group (Subject)
STATE STREET CORP (Filed by)
STATE STREET CORP (Filed by)
Form SC 13G
01/10/2024
3:57 PM
BAKER BROS. ADVISORS LP (Filed by)
Replimune Group (Subject)
Form SC 13G/A
01/08/2024
7:00 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
4:15 PM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
6:19 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
7:00 PM
Replimune Group (Issuer)
Sarchi Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
7:01 PM
Replimune Group (Issuer)
Xynos Konstantinos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
4:03 PM
Replimune Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
11/07/2023
7:15 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
7:03 PM
Hill Emily Luisa (Reporting)
Replimune Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2023
7:04 PM
Hill Emily Luisa (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
7:15 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
8:02 PM
Esposito Pamela (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
8:17 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
7:30 PM
Esposito Pamela (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:30 PM
Esposito Pamela (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
8:04 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:45 AM
Replimune Group (Filer)
Form S-3ASR
08/03/2023
7:09 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:11 AM
Replimune Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2023
7:00 PM
Replimune Group (Issuer)
Sarchi Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/20/2023
7:56 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
8:00 PM
Esposito Pamela (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:27 PM
Esposito Pamela (Reporting)
Replimune Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
8:00 PM
Patel Sushil (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
8:01 PM
Lewis Tanya (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:29 PM
Lewis Tanya (Reporting)
Replimune Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
4:07 PM
Patel Sushil (Reporting)
Replimune Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
7:11 AM
Replimune Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:13 AM
Peeples-Dyer Veleka (Reporting)
Replimune Group (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2023
7:13 AM
Peeples-Dyer Veleka (Reporting)
Replimune Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:REPL) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners